Join us at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Thursday 10th July for an expert-led discussion exploring the latest ...

Rapidly growing pharmaceutical services platform announces the addition of accomplished executives to the organization’s ...

AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan) has been granted accelerated approval by the US Food ...

Medical affairs, situated at the intersection of data and dialogue, is primed to lead this shift. By partnering with ...

PMGroup Worldwide and Visions4Health have launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...

The first patient in the UK has been treated by the NHS with CSL Behring’s haemophilia B gene therapy Hemgenix (etranacogene ...

Instead, identifying early-stage individuals necessitates biomarker-based screening, which adds layers of complexity to an ...

Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, ...

The Specials lab manufactures and supplies Specials drug tariff and non-tariffed unlicensed medicines (commonly known as ‘specials’) to community Pharmacists, Doctors, Vet Surgeons and Hospitals – ...

Global Engage produces high level conferences and summits for the Pharmaceutical, Medical and Technology sectors. With an experienced team of researchers and cutting edge speakers, we provide you with ...

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...